Novartis India Ltd

NSE: NOVARTIND · BSE: 500672 · Pharmaceuticals & Biotechnology · 10 announcements

Share price: ₹1,961.40
Market cap: ₹4,843 Cr
Revenue (annual): ₹354.3 Cr
Net profit (annual): ₹93.18 Cr
P/E (TTM): 49.5×Sector 50.4×
Promoter holding: 70.68%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Annual General Meeting 2 Partnership 1 Other Announcement 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 Sep 2026 15:01 IST BSE

Earnings Call

Novartis India Earnings Call Transcript: Key Takeaways

Novartis India transition to ChrysCapital ownership (70.68%), pivoting from a partner-led model to a direct, in-house commercial platform focusing on chronic therapies like cardiology and ophthalmology.

Open call summary → Read the filing ↗

11 Sep 2026 15:50 IST BSE

Earnings Call

Novartis India Investor Presentation: Key Takeaways

Novartis India Limited (NIL) shifts to a direct-to-market model under new ownership by ChrysCapital, acquiring the 'Minipress' brand for ₹1,250 Cr and in-licensing an ophthalmic portfolio.

Open call summary → Read the filing ↗